Prevalence of Thrombosis in COVID-Patients

Completed

• Conditions: Covid19

• Registration Number: NCT04615026
• Lead Sponsor: University Hospital Augsburg

Brief Summary

Examination of the prevalence of thrombosis in COVID-patients, especially in an out-patient setting. Assessment by duplex sonography. If thrombosis is detected, we will correlate it with immunity status. Assessment of health issues and cognitive function as late complication after infection.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2020-11-03
• Study First Submitted QC: 2020-11-03
• Study Start: 2020-11-04
• Study First Posted: 2020-11-04
• Primary Completion: 2021-06-30
• Study Completion: 2021-06-30
• Status Verified: 2022-05
• Last Update Submitted: 2022-05-30
• Last Update Posted: 2022-06-02

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 525

Inclusion Criteria

• SARS CoV 2 positive swap, at least 4 weeks after infection

Exclusion Criteria

• under 18 years old no consent anemia

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
prevalence of thrombosis	20 minutes

Secondary Outcome Measures

Name	Time	Method
Assessment of late complications	20 minutes
correlation to immunity	20 minutes

Trial Locations

Locations (1)

University Hospital Augsburg; 🇩🇪 Augsburg, Germany